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Abstract
Some studies have linked bilingualism with a later onset of dementia, Alzheimer’s disease (AD), and mild cognitive impairment
(MCI). Not all studies have observed such relationships, however. Differences in study outcomes may be due to methodological
limitations and the presence of confounding factors within studies such as immigration status and level of education. We
conducted the first systematic review with meta-analysis combining cross-sectional studies to explore if bilingualism might
delay symptom onset and diagnosis of dementia, AD, and MCI. Primary outcomes included the age of symptom onset, the age at
diagnosis of MCI or dementia, and the risk of developing MCI or dementia. A secondary outcome included the degree of disease
severity at dementia diagnosis. There was no difference in the age of MCI diagnosis between monolinguals and bilinguals [mean
difference: 3.2; 95% confidence intervals (CI): −3.4, 9.7]. Bilinguals vs. monolinguals reported experiencing AD symptoms
4.7 years (95% CI: 3.3, 6.1) later. Bilinguals vs. monolinguals were diagnosed with dementia 3.3 years (95% CI: 1.7, 4.9) later.
Here, 95% prediction intervals showed a large dispersion of effect sizes (−1.9 to 8.5). We investigated this dispersion with a
subgroup meta-analysis comparing studies that had recruited participants with dementia to studies that had recruited participants
with AD on the age of dementia and AD diagnosis between mono- and bilinguals. Results showed that bilinguals vs. monolinguals were 1.9 years (95% CI: −0.9, 4.7) and 4.2 (95% CI: 2.0, 6.4) older than monolinguals at the time of dementia and AD
diagnosis, respectively. The mean difference between the two subgroups was not significant. There was no significant risk
reduction (odds ratio: 0.89; 95% CI: 0.68–1.16) in developing dementia among bilinguals vs. monolinguals. Also, there was
no significant difference (Hedges’ g = 0.05; 95% CI: −0.13, 0.24) in disease severity at dementia diagnosis between bilinguals
and monolinguals, despite bilinguals being significantly older. The majority of studies had adjusted for level of education
suggesting that education might not have played a role in the observed delay in dementia among bilinguals vs. monolinguals.
Although findings indicated that bilingualism was on average related to a delayed onset of dementia, the magnitude of this
relationship varied across different settings. This variation may be due to unexplained heterogeneity and different sources of bias
in the included studies. Registration: PROSPERO CRD42015019100.
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Key Points
& Meta-analytic results showed that bilinguals vs. monolinguals were older at the time of Alzheimer’s symptom onset and
dementia diagnosis.
& Meta-analytic results did not show a reduction in the risk of developing dementia among bilinguals vs. monolinguals.
& Several sources of bias were identified, including poor measurement of participants’ language profiles with analytic samples
including differing dementia aetiologies.
Keywords Bilingualism . Multilingualism . Mild cognitive impairment . Dementia . Alzheimer’s disease . Meta-analysis

Introduction
Rationale
Approximately 43.8 million people lived with dementia
worldwide in the year 2016 (Nichols et al., 2019) and this
number is projected to increase to 115.5 million people by
2050 (Prince et al., 2013). The global economic cost of dementia is estimated to surpass US$2 trillion per year by 2030
(Wimo et al., 2017). A five-year delay in the onset of
Alzheimer’s disease (AD), the most common form of dementia, could reduce the number of patients living with the disease
worldwide by 57%, thereby alleviating the associated economic costs by half (Sperling et al., 2011). Therefore, identifying modifiable lifestyle factors that can slow or delay the
onset of dementia is a world’s public health priority (WHO,
2017; Wortmann, 2012).
One such factor may be bilingualism, which is the ability to
speak two languages (Luk & Bialystok, 2013). This hypothesis
comes from studies showing that bilinguals develop mild cognitive impairment (MCI), dementia, and AD, 4–7 years later
than monolinguals (Alladi et al., 2013; Bialystok, Craik, Binns,
Ossher, & Freedman, 2014; Bialystok, Craik, & Freedman,
2007). Others, however, have not documented such differences
(Lawton, Gasquoine, & Weimer, 2015; Yeung, John, Menec, &
Tyas, 2014). Also, while longitudinal prospective studies
showed no risk reduction among bilinguals relative to monolinguals (Ljungberg, Hansson, Adolfsson, & Nilsson, 2016;
Yeung et al., 2014; Zahodne, Schofield, Farrell, Stern, &
Manly, 2014), foreign language education during adolescence
has been associated with reduced risk of MCI later in life
(Wilson, Boyle, Yang, James, & Bennett, 2015). Some authors
have argued that confounding factors including migration status and education may explain some differences in study outcomes in cross-sectional and longitudinal studies (FullerThomson, 2015; Fuller-Thomson & Kuh, 2014).
One systematic review concluded that “public health policy
should… remove recommendations regarding bilingualism as
a strategy to delay dementia” (Mukadam, Sommerlad, &
Livingston, 2017). However, the authors conducted a metaanalysis of only four longitudinal prospective studies without
performing meta-analyses on cross-sectional reports.
Moreover, while studies without a monolingual control group

were excluded from this review (Mukadam et al., 2017), their
meta-analysis included one study (Sanders, Hall, Katz, &
Lipton, 2012) which did not clearly define the control group
as monolingual. That review did not include age at MCI diagnosis as an outcome or studies published more recently (Hack,
Dubin, Fernandes, Costa, & Tyas, 2019; Ljungberg et al.,
2016; Perani et al., 2017; Ramakrishnan et al., 2017; Zheng
et al., 2018). As such, before suggesting that bilingualism
should not be recommended as a strategy for delaying dementia, a careful re-evaluation of the available evidence is necessary (Del Maschio, Fedeli, & Abutalebi, 2018).

Objectives
Differences in study outcomes in the field of bilingualism and
dementia research as well as the need to identify strategies to
delay the onset of dementia as highlighted in the Global plan
on the public health response to dementia 2017–2025 by the
World Health Organization (WHO, 2017) prompted this systematic review. We assessed whether bilingualism relative to
monolingualism might delay the age at which participants
experienced the initial symptoms of AD and delay the age at
which participants were diagnosed with MCI or dementia. We
also examined whether bilingualism might be associated with
a lower risk of dementia. The primary objectives were to review cross-sectional and longitudinal prospective studies investigating (i) differences in the age of symptom onset and age
at diagnosis of MCI or dementia between older monolinguals
and bilinguals, and (ii) the relationship between bilingualism
relative to monolingualism and risk of dementia in older cognitively intact adults. A secondary objective was to investigate
differences in disease severity at dementia diagnosis between
older monolinguals and bilinguals.

Methods
Search Strategy and Selection Criteria
This systematic review with meta-analyses accords with the
Preferred Reporting Items for Systematic Reviews and Meta-
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Analyses Statement (PRISMA; Moher, Liberati, Tetzlaff, &
Altman, 2010). Eligible studies had to compare monolingual
to bilingual participants on at least one of the following outcomes: reported age of symptom onset or age at diagnosis for
MCI or dementia, degree of cognitive impairment at dementia
diagnosis, or risk of dementia or MCI. Given the lack of a
clear uniform definition of bilingualism in the literature, we
included studies independently of the way bilingualism was
operationalized or measured, or whether proficiency in the
second language had been objectively assessed. We included
studies that had recruited participants with MCI or dementia
as assessed using clinical measures such as the National
Institute of Neurological and Communicative Disorders and
Stroke and the Alzheimer’s Disease and Related Disorders
Association (NINCDS-ADRDA) as well as cognitively intact
individuals. We excluded studies without a group of monolinguals. We also excluded reports, conference abstracts, reviews, commentaries, editorials, letters, news articles, case
series, and discussion forums, as well as grey literature including non-peer reviewed empirical studies. We searched crosssectional, prospective, case-control studies, and randomized
controlled trials across several databases including
CINHAL, The Cochrane Library, PubMed, PsycINFO,
LILACS, and Embase. Filters were used to exclude animal
studies, but no restrictions were placed on time and language.
The initial search was performed on September 3, 2015 and
refreshed several times with the last refresh being complete on
December 5, 2018. We used similar keywords and criteria for
each search.
The database searches were conducted by S.B., while the
screening for title and abstract as well as the full-text screening
was conducted independently by pairs of review authors
(S.B., T.J.F., and J.J.H.). Data extraction was completed independently by pairs of review authors (S.B., M.F., T.J.F., and
J.P.). We used Covidence software for each of these steps
(Innovation, 2017). Disagreements were resolved through
consensus and discussion with a third review author. We requested additional information from corresponding authors
when necessary. Details of the protocol for this systematic
review were registered a priori (PROSPERO 2015
CRD42015019100).
Embase search strategy (example) ‘dementia’/exp. OR ‘dementia’ OR ‘Alzheimer disease’/exp. OR ‘Alzheimer disease’
OR ‘frontotemporal dementia’/exp. OR ‘frontotemporal dementia’ OR ‘multiinfarct dementia’/exp. OR ‘multiinfarct dementia’ OR ‘mild cognitive impairment’/exp. OR ‘mild cognitive impairment’ OR ‘memory disorder’/exp. OR ‘memory
disorder’ OR ‘Parkinson disease’/exp. OR ‘parkinson disease’
AND (‘multilingualism’/exp. OR ‘multilingualism’) OR
‘multilingualism’/exp. OR ‘multilingualism’ OR ‘bilingualism’/exp. OR ‘bilingualism’ OR ‘English as a second language’/exp. OR ‘English as a second language’ AND

3

[article]/lim AND ([adult]/lim OR [middle aged]/lim OR
[aged]/lim OR [very elderly]/lim) AND [humans]/lim.

Study Selection
The number of studies screened and included for quantitative
synthesis is presented in Fig. 1. The quantitative synthesis
included three cross-sectional studies with age at MCI diagnosis (Table 1) and 16 cross-sectional studies with age at AD
symptom onset and age at dementia or AD clinical diagnosis
(Table 2). There was one longitudinal prospective study with
the risk of MCI as the outcome (Table 3) and five with the risk
of dementia as the outcome (Table 4).

Description of Mild Cognitive Impairment
and Dementia
Years before clinical diagnosis of a dementia-related disorder,
an individual may experience MCI which can either be of the
amnestic or non-amnestic type (Pandya et al., 2016). The former is marked by memory impartment more severe than
would be expected for the age of the individual and this is a
risk factor for AD. In the non-amnestic type, other cognitive
abilities (e.g., language) rather than memory are affected and
this is a risk factor mainly for other types of dementia.
However, some individuals who experience MCI of either
type do not necessarily progress to AD or other forms of
dementia (Pandya et al., 2016). Dementia is a progressive
clinical syndrome presenting with impairment in cognition,
daily functioning, and changes in behavior in the absence of
any impairment in consciousness (Vinters, 2015). While dementia is an umbrella that describes a significant cognitive and
functional decline usually caused by a wide range of neurodegenerative diseases, AD has a specific etiology marked by a
progressive and irreversible amnestic disorder followed by a
decline in other cognitive abilities and behavior as well as
neuropsychiatric dysfunctions resulting in total dependence
(Vinters, 2015). Diagnosis of AD is based on clinical presentation (e.g., Diagnostic and Statistical Manual of Mental
Disorders) and neuropsychological assessment while neuroimaging is used to support clinical evaluation. However, a
definite diagnosis can only be given by the NINCDSADRDA criteria with histopathological evidence supporting
clinical diagnosis (Dubois et al., 2007).

Data Extraction and Risk of Bias
We extracted information on sample size, sex, mean age at
diagnosis, education level, language measure, measures to
diagnose dementia, dementia subtype, degree of cognitive
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Data Analysis
Our primary outcome measures were the age of symptom
onset and age at diagnosis of MCI or dementia and the risk
of developing dementia. A secondary outcome included the
degree of disease severity at dementia diagnosis. Here, age at
diagnosis was defined as the age at which participants were
diagnosed with MCI, AD, or dementia and age of symptom
onset was defined as the participants’ or informants’ retrospective recall of the age at which the first symptoms of cognitive impairment started. However, most studies that reported
the age of symptom onset included participants with AD, not
dementia. Therefore, we could only conduct a meta-analysis
on the age of symptom onset for participants with AD, not
dementia. Our secondary outcome was the degree of cognitive
impairment as measured by the Mini-Mental State
Examination (MMSE; Folstein, Folstein, & McHugh, 1975)
during dementia or AD diagnosis, and dementia risk.
All the meta-analyses conducted here were based on
random-effects models at an alpha level of .05 with the
Knapp-Hartung adjustment (IntHout, Ioannidis, & Borm,
2014). Because studies did not provide individual-level data,
we retrieved summary data. One study included two monolingual groups: one Mandarin and one Cantonese (Zheng et al.,
2018). To increase the sample size, we combined the sample
sizes, means, and standard deviations on the age of symptom
onset, age of clinical diagnosis, and degree of cognitive

Records identified through database
searching
(n = 2491)

Additional records identified
through other sources
(n = 4)

Eligibility

Screening

Records after duplicates removed
(n = 2205)

Records screened
(n = 2204)

Full-text articles assessed
for eligibility
(n = 128)

Studies included in
qualitative synthesis
(n = 21)

Included

Fig. 1 Prisma flow diagram
showing the final number of
included studies meeting
selection criteria according to
PRISMA (Preferred Reporting
Items for Systematic reviews and
Meta-Analyses) 2009

Identification

impairment outcomes, and study results. Two authors (SB and
MF) independently assessed risk of bias at both the study and
outcome level by using the modified version of the
Newcastle-Ottawa Scale (NOS) to assess risk of bias for
cross-sectional studies (Wells et al., 2015). The modified
NOS allows to allocate a maximum of 10 stars to each study
across three domains: selection of study groups (range 0–5),
comparability of study groups (range 0–2), and exposure/
outcome ascertainment (range 0–3). For longitudinal studies,
we used the original version of the NOS for cohort studies,
which allows allocating a maximum of nine stars across the
same domains as in the modified version.
Because the included studies were sufficiently similar regarding the research question, methodology, and outcome, we
conducted a quantitative synthesis of the data by metaanalyzing effect sizes from included studies.
In cross-sectional studies, the authors reported the age of
symptom onset for AD and age of clinical diagnosis for MCI,
dementia, and AD as absolute numbers in years. Longitudinal
prospective studies reported the risk of dementia as relative
risk – the risk of developing dementia in bilinguals relative to
monolingual controls and odds ratio – the odds of developing
dementia given language status (i.e., bilingualism vs.
monolingualism). One longitudinal prospective study reported the proportional hazard ratios in estimating the relationship
between early foreign language instruction and the risk of
developing MCI later in life (Wilson et al., 2015).

Studies included in
quantitative synthesis
(meta-analysis)
(n = 16 cross-sectional)
(n = 5 longitudinal)

Records excluded
(n = 2076)

107 Studies excluded
21 Conference abstracts
18 Wrong patient population
16 Review articles
16 Wrong outcomes
13 Commentary
5 Wrong comparators
4 Case series
3 News articles
2 Discussion forums
2 Duplicate
2 Letter
2 Report
2 Wrong study design
1 Editorial

ML: 28 (50%);
BL: 26 (56%)

ML (SDaMCI): 49
(55%)
BL (SDaMCI): 19 (32%)
ML (MDaMCI):
22 (45%)
BL (MDaMCI): 21
(43%)
ML: 22 (18.2%)
BL: 93 (20.4%)

Bialystok et al., 2014

Ossher et al. 2012

ML: 15.5 (3.8)
BL: 14.3

Education level

LSBQ

MCI

Language MCI diagnosis
measure and type

ML: 58.1 (11.4); 55.8
ML: 10.4 (3.7)
(12.2)
BL: 15.5 (3.3)
BL: 65.2 (9.9); 63.2 (10.1)

NA

Clinicians used Petersen
criteria for final
diagnosis;
MCI: amnestic MCI &
non-amnestic MCI

ML (SDaMCI): 74.9 (6.9) ML (SDaMCI): 14.7 (2.5) Questionnaire Clinical interview including
BL (SDaMCI): 79.4 (6.3) BL (SDaMCI): 14.5 (3.9)
neuropsychological
ML (MDaMCI): 75.2 (8.5) ML (MDaMCI): 14.9
tests; SDaMCI,
BL (MDaMCI): 72.6 (7.2)
(3.3)
MDaMCI
BL (MDaMCI): 15.0
(3.3)

ML: 66.5 (12.3)
BL: 70.0 (10.7)

Mean age of
diagnosis &
symptom onset

3.5 (−1.77–8.77)

Age of diagnosis

NA

7.1 (2.36–11.84)

ML (SDaMCI): 27.7 (1.6) SDaMCI: 4.50
BL (SDaMCI): 27.6 (1.9)
(0.93–8.07)
ML (MDaMCI): 27.9
MDaMCI: −2.60
(1.4)
(−7.32–2.12)
BL (MDaMCI): 27.7
(1.8)

ML: 29 (1.4)
BL: 28.4 (1.9)

MMSE scores

Cognitive
impairment

7.4
NA
(2.46–12.34)

4.7
0.6
(0.97–10.3(−0.17–1.37)
7)
NA
SDaMCI: −0.1
MDaMCI: −0.2

Age of
onset

Effect sizes (MD = BL age minus ML age, 95%:
CI)

ML: Monolinguals; BL: Bilinguals; Mild Cognitive Impairment; SDaMCI: Single domain amnestic MCI; MDaMCI: Multiple domain MCI; LSBQ Language and Social Background Questionnaire;
MMSE: Mini-Mental State Examination; CI: Confidence Intervals; MD: Mean Difference; NA: Not Available

Ramakrishnan et al.,
2017

N (% of females)

Study characteristics

Cross-sectional studies investigating the relationship between bilingualism and MCI.

Study

Table 1
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ML: 72 (52.8%)
BL: 121 (36.4%)

ML: 257 (49.0%)
BL: 391(25.1%)

ML: 35 (54%)
BL: 40 (55%)

ML: 91 (53%)
BL: 93 (59%)

ML: 379 (63%)
BL: 253 (51%)
ML: 49 (45%)
BL: 37 (57%)

Alladi et al., 2017

Alladi et al., 2013

Bialystok et al., 2014

Bialystok 2007

Chertkow et al., 2010

ML: 40 (52.5%)
BL: 45 (71%)
ML: 19 (70%)
BL: 20 (70%)

Perani er al., 2017

ML: 69 (69%)
BL: 65 (69%)

ML (Cantonese):
48 (85%)

Woumans et al., 2015

Zheng et al., 2018

Schweizer et al., 2012

ML: 54 (65%)
BL: 27 (63%)

Lawton et al., 2015

Craik, Bialystok, & Freedman ML: 109 (55%)
2010
BL: 102 (59%)

Clare et al., 2016

N (% of
females)

Diagnosis

ML: 72.5 (9.4)
BL: 77.3 (10.5)

ML: 71.4 (4.9)
BL: 77.1 (4.5)
ML: 77.3 (6.8)
BL: 78.9 (7.7)

Dementia
ML: 61.0 (9.5), 58.4
(9.3)
BL: 64.2 (9.4), 61.7
(9.1)
Dementia
ML: 63.4 (11.4), 61.1
(11.4)
BL: 68.1 (10.0), 65.6
(10.0)
AD (onset)
ML: 65.4 (10.0)
BL: 68.6 (9.6)
ML: 74.2 (11.2), 70.9
(11.0)
BL: 81.4 (8.4), 78.2
(8.9)
Dementia
ML: 75.4 (9.3); 71.4
(9.6)
BL: 78.6 (8.4); 75.5
(8.5)
AD
ML: 75.8 (9.8)
BL: 79.2 (8.7)
ML: 76.7 (7.8)
BL: 77.6 (7.2)
ML: 76.2 (8.8), 73.7
(9.9)
BL: 79.3 (6.8), 76.9
(7.1)
ML: 76.5 (10), 72.6
(10.0)
BL: 80.8 (7.7), 77.7
(7.9)
ML: 81.10 (NA)
BL: 79.31 (NA)

Mean age
of diagnosis &
symptom onset

Study characteristics

ML (Cantonese):
4.92 (3.85)

ML: 13.5 (2.8)
BL: 14.7 (3.1)

ML: 10.5 (4.07)
BL: 8.26 (4.55)
ML: 13.6 (3.5)
BL: 11.6 (4.5)

ADDTC
NINCDS–ADRDA; VaD
Possible and probable AD
NIAAA; probable AD

NINCDS-ADRDA;
probable AD

NINCDS-ADRDA;
probable AD
ICD-10; AD

NINCDS–ADRDA; AD,
possible AD,
dementia due to other
neurodegenerative
disorders, and CVD

NA; Probable AD

ML (Cantonese): 12.25
(5.39)

ML: 24.2 (3.1)
BL: 23.8 (3.4)

4.80 (1.43–8.17)

1.60 (−2.95–6.15)

5.70 (3.71–7.71)

1.79 (−4.55–0.97)

ML: 78.87 (9.90)
BL: 79.56 (15.57)

4.6
(1.17–8.03)

NA

NA

NA

(2.64–7.56)

3.21
(−0.65–7.07)

1.22 (−0.16–2.60)

5.1

NA

4.3 (1.87–6.63)

ML: 21.10 (4.84)
BL: 22.40 (4.19)
ML: 23.2 (3)
BL: 22.1 (5.1)

(2.72–11.88)
4.1 (1.4–6.74)

7.3

Dementia
4.5
(2.83–6.17)
AD
NA

FTD
3.3
(0.61–5.99)

Age of
onset

0.9 (− 0.31–2.11)

Dementia
3.2 (0.62–5.78)
AD
3.3 (0.241–6.505)

7.2 (2.68–11.72)

ML: 21.5 (5.7)
BL: 20.4 (5.6)

ML: 23.1 (3.9)
BL: 22.9 (4.3)
ML: 23.90 (3.19)
BL: 22.68 (3.16)

ML: 21.3 (6.4)
BL: 20.1 (7.1)

ML: 23.4 (3.8)
BL: 22.3 (4.5)

Dementia
4.7 (3.03–6.37)
AD
3.2 (0.67–5.73)

DSM-IV; AD, VaD, mixed
AD with CVD, FTD,
DLB

ML: 16.7 (7.5)
BL: 18.9 (8.0)

Age of diagnosis

FTD
3.2 (0.43–5.97)

MMSE/3MSE
scores

0.40 (−0.70–1.50)

−1.10 (−3.87–1.67)

1.3 (−0.65–3.25)

0.69 (−4.97–6.35)

1.1 (−0.43–2.63)

1.94 (−1.33–5.21)

0.2 (−0.45–0.85)

AD
1.2 (−3.24–5.64)

1.1 (−0.83–3.03)

Dementia
NA
AD
2.2 (0.97–3.43)

FTD
2.2 (−0.81–5.21)

Cognitive
impairment

Effect sizes (MD = BL age minus ML age, 95%: CI)

ML: 15.9 (10.3)
MMSE, ACE-R, FrSBe;
BL: 18.1 (10.2)
bvFTD,
PNFA, SD, FTD-MND,
CBD, PSP

Dementia
diagnosis and type

CDR; probable AD
Interview with
patient
and
significant-other
Neurologist in consultation
Patient and
with a
caregiver
neuropsychologist;
interviews using
AD
Likert scale
BAT
Two neurologists delivered
the diagnosis using the

Questionnaire

ARSMA-II

NA

ML: 12.6 (4.1)
BL: 10.6 (5.1)

ML: 4.99 (4.17)
BL: 7.70 (4.88)

Patient & caregiver
interviews
LQ-SV

ML: 10.9 (3.5)
BL: 10.7 (3.8)
ML: 12.31 (3.04)
BL: 11.84 (2.46)

Medical records

LSBQ

ML: 12.5 (3.7)
BL: 12.2 (4.9)

ML: 12.4 (3.8)
BL: 10.8 (4.2)

Family member
interview

Case records

ML: 6.9 (5.3)
BL: 13.9 (4.3)

ML: 5.9 (5.1)
BL: 12.9 (4.9)

Language
measure

Education
level

Cross-sectional studies on the relationship between bilingualism and dementia or AD.

Study

Table 2
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ML: 913 (60.4%)
BL: 81 (61.7%)
ESL: 622 (57.4%)

ML: 77.4 (6.7)
BL: 77.0 (6.5)
ESL: 77.1 (7.1)

ML: 57.82 (6.42)
ML: 100 (58%)
Early BL: 81 (54.3%) Early BL: 56.82 (6.48)
Late BL: 97 (60.8%) Late BL: 57.56 (6.57)

ML: 10.4 (2.9)
BL: 11.9 (4.2)
ESL: 8.1 (3.7)

ML: 12.33 (3.37)
Early BL: 14.35
(3.76)
Late BL: 14.98
(3.77)

Education level

ML (Mandarin):
10.95 (3.28)
BL: 10.79 (4.32)

ML (Cantonese):
67.7 (9.9) ML
(Mandarin): 67.0
(9.1)
BL: 74.4 (9.4)
Onset
ML (Cantonese): 63.9
(9.7)
ML (Mandarin): 63.4
(8.9)
BL: 70.9 (9.4)
Mean age

ML (Mandarin): 20
(45%)
BL: 61 (57%)

N (% of females)

Education
level

Mean age
of diagnosis &
symptom onset

N (% of
females)

Study characteristics

Dementia diagnosis
and type
Cognitively intact

DSM-IIIR; Dementia

Self-repot

NINCDS–ADRDA;
probable AD

Dementia
diagnosis and type

Language
measure
BLPQ

Language
measure

ML: 89.0 (8.1)
BL: 89.3 (6.7)
ESL: 83.3 (11.0)

ML: 197 (31%), 440
(69%);
BL: 86 (20%), 344
(80%)

The prevalence of subjects
in preclinical AD
stage 1 (abnormal
amyloid),
stage 2 (abnormal
amyloid
and tau), and SNAP
(abnormal tau) was
significantly
different (p = 0.02)
between
early bilinguals (stage 1:
3.6%;
stage 2: 1.8%; and SNAP:
1.8%) and monolinguals
(stage 1: 11.9%; stage 2:
6.8%;
and SNAP: 6.8%)
Bilingualism was not
associated
with risk of developing
dementia
ML: (stage 1: 11.9%;
stage
2: 6.8%; and SNAP:
6.8%); Early BL:
(stage 1: 3.6%; stage
2: 1.8%; and SNAP:
1.8%)

ML: 28.44 (1.34)
Early BL: 28.81 (1.09)
Late BL: 28.81 (1.09)

Cognitive
impairment

Rate ratio

Age of
onset

Prevalence

Age of diagnosis

MMSE/3MSE scores

ML (Mandarin): 15.75
(6.75)
BL: 16.43 (6.46)

MMSE/3MSE
scores

Effect sizes (MD = BL age minus ML age, 95%: CI)

ML: Monolinguals; BL: Bilinguals; AD: Alzheimer’s Disease; FTD: Frontotemporal Dementia; bvFTD: behavioural variant Frontotemporal Dementia; PNFA: Progressive Non Fluent Aphasia; SD:
Semantic Dementia; FTD-MND: Frontotemporal dementia-motor neuron disease; CBD: Cortico-Basal Degeneration; PSP: Progressive Supranuclear Palsy; VaD: Vascular Dementia; CVD: Cardiovascular
Disease; DLB: Dementia with Lewy bodies; SNAP: Suspected Non-Alzheimer Pathophysiology; LSBQ Language and Social Background Questionnaire; LQ-SV Language Questionnaire – Short Version;
ARSMA-II Acculturation Rating Scale for Mexican Americans; BLPQ Bilingual Language Profile Questionnaire; BAT Bilingual Aphasia Test; MMSE: Mini-Mental State Examination; 3MS: Modified
Mini-Mental State; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders Version Four; (ADDTC) NINCDS-ADRDA: (Alzheimer Disease Diagnostic and Treatment Centers); National Institute
of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; ICD-10: International Statistical Classification of Diseases and Related Health
Problems; CDR: Clinical Dementia Rating; DSM-IIIR: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; NA: CI: Confidence Intervals; MD: Mean Difference; Not Available

Yeung et al., 2014

Estanga et al., 2017

Study

Table 2 (continued)
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impairment from the Mandarin and Cantonese group to form
one monolingual group. For these calculations, we used the
formula provided by the Cochrane Collaboration (Higgins &
Green, 2016). For degree of cognitive impairment at dementia
diagnosis, we presented MMSE scores (range: 0–30) as
Hedges’ g between monolinguals and bilinguals because one
study (Lawton et al., 2015) reported scores from the Modified
Mini-Mental Status Examination (3MSE), which uses a scale
from 0 to 100 points. Also, as not all prospective studies
provided the same outcome results (one study provided hazard
ratios and others provided log odds ratios), we extracted the
unadjusted raw values of participants who had remained free
of dementia and of those who had converted to dementia from
the mono- and bilingual group. These values are unadjusted
values but it was necessary to use these in order to combine
results into a meta-analysis.
Data were analyzed using Comprehensive Meta-Analysis
Software: version 3 (Borenstein, Rothstein, & Cohen, 2005).
For cross-sectional studies, we presented mean differences
between monolinguals and bilinguals for our primary and secondary outcomes (mean age in years and mean MMSE
scores). For longitudinal studies, we presented odds ratio.
We presented 95% confidence intervals (CI) around the
pooled estimates (Riley, Higgins, & Deeks, 2011). We also
computed 95% prediction intervals (PI), which reflect the distribution of effect sizes across different settings and estimate
the expected effect sizes for future settings (IntHout,
Ioannidis, Rovers, & Goeman, 2016). However, we computed
PIs for meta-analyses with at least 10 studies (Hedges &
Vevea, 1998). We used tau-squared (T2) to investigate
between-study heterogeneity, with a non-zero T2 value indicating between-study heterogeneity. To investigate smallstudy effects, we generated funnel plots for meta-analyses that
include at least 10 studies (Lau, Ioannidis, Terrin, Schmid, &
Olkin, 2006). To explore the impact that imputing missing
studies might have on the pooled estimate, we conducted
Duval and Tweedie’s trim and fill test (Duval & Tweedie,
2000). We did not conduct formal tests for funnel plot asymmetry in meta-analyses with fewer than 10 studies (Sterne
et al., 2011).
Because we did not pre-specify potential covariates and to
avoid data dredging (Thompson & Higgins, 2002), we restricted our investigation of heterogeneity to immigration status (Fuller-Thomson & Kuh, 2014; Mukadam et al., 2017) and
dementia etiology due to its clinical relevance (Bialystok,
Abutalebi, Bak, Burke, & Kroll, 2016; IntHout et al., 2016).
In two subgroup meta-analyses, we compared studies that had
recruited participants with dementia (irrespective of etiology)
to studies that had recruited participants with AD (specific
etiology) on the age of dementia and AD diagnosis. In the
other subgroup meta-analysis, we compared studies explicitly
mentioning that the statistical analyses had been adjusted for
immigration status or at least that the analytic cohort did not
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include migrants to studies not explicitly mentioning whether
the statistical analyses had adjusted for migration status
or whether the analytic sample had included migrants.
We reported the pooled estimates for heterogeneity in
subgroup meta-analyses.

Results
Data Collection Process
We extracted demographic data including sample size, percentage of females in each group, and education level.
Moreover, we extracted methodological data including the
operationalization and measurement of participants’ language
profiles, type of diagnosis (i.e., MCI, dementia, or AD), as
well as the measurement tools used for making the clinical
diagnosis of MCI or any dementia. We also extracted data
for each outcome in each group including mean age of dementia diagnosis, mean age of dementia symptom onset, risk of
MCI or dementia, and degree of cognitive impairment. We
were able to extract sufficient data on age of MCI (k = 4)
and dementia clinical diagnosis (k = 13), AD symptom onset
(k = 7), degree of cognitive impairment (k = 12), and risk of
dementia (k = 5) to conduct a meta-analysis on each of these
outcomes. The total number of participants in cross-sectional
studies was 4671 including 2376 monolinguals and 2295 bilinguals (Table 1 and 2). There were 121 monolinguals and
159 bilinguals in cross-sectional studies with MCI diagnosis
as an outcome (Table 1), and 2256 monolinguals and 2136
bilinguals in studies with dementia diagnosis as an outcome
(Table 2). There were six longitudinal prospective studies
comprising a total of 4227 participants (Tables 3 and 4).

Study Characteristics
The operationalization of bilingualism differed across studies
including: “had spent the majority of their lives, at least from
early adulthood regularly using at least two languages”
(Bialystok et al., 2007; Craik, Bialystok, & Freedman,
2010), “the ability to communicate in two or more languages
in interaction with other speakers of these same languages”
(Alladi et al., 2013; Alladi et al., 2017), “individuals had spent
the majority of their lives, beginning at least in early adulthood, speaking two or more languages fluently—ideally daily,
but at least weekly” (Bialystok et al., 2014; Chertkow et al.,
2010; Ossher, Bialystok, Craik, Murphy, & Troyer, 2012),
“able to communicate fluently at least in 2 languages and
made regular use for both” (Estanga et al., 2017), “ability to
meet the communicative demands of the self and the society in
their normal functioning in 2 or more languages in their interaction with other speakers of any or all of these languages”
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(Ramakrishnan et al., 2017), “fluent in a second language and
had used both languages consistently throughout most of his
or, her life” (Schweizer, Ware, Fischer, Craik, & Bialystok,
2012), “determined on the basis of second language proficiency and frequency of use” (Woumans et al., 2015) or did not
apply a specific definition (Lawton et al., 2015; Ljungberg
et al., 2016; Perani et al., 2017; Wilson et al., 2015; Yeung
et al., 2014; Zahodne et al., 2014). One study used more strict
definitions for monolingualism and bilingualism including
“speaking English for all or most of one’s life and being fluent
in English, but not in any other language” and “speaking both
Welsh and English for all or most of one’s life and being fluent
in both languages, but not in any other languages”, respectively (Clare et al., 2016).
Studies used different types of measurements for bilingualism (Tables 1, 2, 3, and 4). While several cross-sectional studies used validated measures including questionnaires to measure bilingualism (Bialystok et al., 2014; Clare et al., 2016;
Estanga et al., 2017; Lawton et al., 2015; Ossher et al., 2012),
others used non-validated methods (Alladi et al., 2013;
Bialystok et al., 2007; Chertkow et al., 2010; Schweizer
et al., 2012; Woumans et al., 2015), or did not report the
method of collection (Craik et al., 2010; Ramakrishnan
et al., 2017). Similarly, one longitudinal study assessed participants’ language profiles with a non-validated measure
(Wilson et al., 2015), two used a questionnaire but did not
report their psychometric properties (Hack et al., 2019;
Ljungberg et al., 2016), while one study validated their measure as part of the study (Zahodne et al., 2014).
There were differences in the type of MCI and dementia across studies (Table 1–4). Four studies recruited
participants with MCI (Bialystok et al., 2014; Ossher
et al., 2012; Ramakrishnan et al., 2017; Wilson et al.,
2015). The type of MCI differed across studies with
two studies recruiting individuals with MCI without describing its subtype (Bialystok et al., 2014; Wilson
et al., 2015), another study recruited individuals with
single and multiple domain amnestic MCI (Ossher
et al., 2012), while still another study recruited individuals with amnestic and non-amnestic MCI
(Ramakrishnan et al., 2017).
The tools for diagnosing MCI and dementia as well as the
dementia subtypes differed across studies (Table 1–4). For
MCI, studies either did not report the method of diagnosis
(Bialystok et al., 2014), diagnosed MCI during a clinical interview with neuropsychological tests (Ossher et al., 2012),
adopted the Mayo Clinic MCI criteria [(Ramakrishnan et al.,
2017) Table 1], or the NINCDS-ADRDA criteria (Wilson
et al., 2015). The diagnosis of dementia was often based on
a clinical interview conducted by medical staff (e.g., a neurologist) and a neuropsychological assessment and using the
NINCDS-ADRDA criteria (Bialystok et al., 2007; Chertkow
et al., 2010; Lawton et al., 2015; Ljungberg et al., 2016), the
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International Classification of Diseases 10 (Clare et al., 2016),
or the Diagnostic and Statistical Manual of Mental Disorders,
4th Edition (Alladi et al., 2013), among others (Table 2).
Studies recruited participants with a wide range of dementia subtypes including the behavioral variant frontotemporal
dementia, progressive non-fluent aphasia, semantic dementia,
frontotemporal dementia-motor neuron disease, corticobasal
degeneration, and progressive supranuclear palsy (Alladi
et al., 2017), AD (Clare et al., 2016; Ljungberg et al., 2016;
Woumans et al., 2015), vascular dementia (Alladi et al., 2013;
Ljungberg et al., 2016; Zahodne et al., 2014), mixed AD with
cardiovascular disease, frontotemporal dementia, dementia
with Lewy bodies (Alladi et al., 2013; Zahodne et al., 2014),
probable AD (Bialystok et al., 2014; Chertkow et al., 2010;
Craik et al., 2010; Lawton et al., 2015; Perani et al., 2017;
Schweizer et al., 2012; Zahodne et al., 2014), possible AD
(Bialystok et al., 2007; Lawton et al., 2015; Zahodne et al.,
2014), dementia due to other neurodegenerative disorders,
cardiovascular disease (Bialystok et al., 2007), preclinical
AD (Estanga et al., 2017), frontal lobe dementia (Ljungberg
et al., 2016), and dementia [(Hack et al., 2019; Yeung et al.,
2014) Table 2].

Risk of Bias for Cross-Sectional Studies
Risk of bias for cross-sectional studies is presented in Table 5.
Most cross-sectional studies employed acceptable sampling
methods (k = 16; 100%), but most did not provide evidence
for power calculations (k = 14; 88%). While some studies (k =
5; 31%) administered a validated measure of language ability,
half of all studies (k = 8; 50%) used non-validated measures,
including self- or proxy-reported measures (e.g., family member) or did not report the method of data collection (k = 2,
13%). Some studies (k = 14, 88%) controlled for important
covariates such as immigration status and education either
methodologically or statistically while others did not control
for any covariates (k = 2, 13%).

Risk of Bias for Longitudinal Studies
Risk of bias for longitudinal studies is presented in Table 6.
All longitudinal studies employed poor sampling methods and
either administered a language questionnaire, of which there
was no mention of the psychometric properties, or they relied
on self-report during a structured interview. Potential confounding factors including age, sex, and apolipoprotein E
(APOE) ε4 allele status (Ljungberg et al., 2016); age, sex,
and years of formal education (Wilson et al., 2015); age,
sex, education, and subjective memory loss (Yeung et al.,
2014); country of origin, gender, education, time spent in the
current home country (United States of America), recruitment
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SD: Standard Deviation; Ed: Education; MMSE: Mini-Mental State Examination; 3MS: Modified Mini-Mental State Examination; ML: Monolinguals; BL: Bilinguals; RR: Relative Risk; OR: Odds
Ratios; HR: Hazard Ratios; NINCDS–ADRDA: (Alzheimer Disease Diagnostic and Treatment Centers) National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association; MCI: Mild Cognitive Impairment

During a mean of 5.8 years (SD = 3.5) of annual follow-up Higher levels (>4 years) of foreign language
evaluations, 396 individuals (41.1%) developed MCI
instruction: HR = 0.687, 95% CI: 0.482, 0.961
Wilson et al., 2015 964 (76.8%), 78.7 (7.4), 14.6 (3.2) Self-report
NINCDS–ADRDA
MCI

Language measure, dementia % with dementia ML/BL %
diagnosis and type
no dementia ML/BL

Effect size
Study characteristics

N (% female); mean age (SD),
Ed, MMSE/3MS
Study

Table 3

Longitudinal prospective study investigating the relationship between bilingualism and MCI.

RR, OR, HR
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wave, and age at enrollment (Zahodne et al., 2014); occupation, education, baseline age, immigration status, APOE ε4
allele status, idea density, and grammatical complexity
(Hack et al., 2019) were controlled for. Finally, all studies
had adequate assessments of the outcome including blind assessments for dementia diagnosis and appropriate follow-up
periods, as well as reported sufficient information on attrition
rate.

Meta-Analyses of Cross-Sectional Studies: Age
of Symptom Onset, Diagnosis and Disease Severity
at Dementia Diagnosis
Age at Alzheimer’s Disease Symptom Onset
The mean difference between mono- and bilinguals at the age
of AD symptom onset was 4.7 years (95% CI: 3.3, 6.1; Fig. 2).
The t value was 8.06 with a two-tailed p < 0.001. Therefore,
bilinguals were significantly older than monolinguals at the
time of AD symptom onset. The Q-value was 6 with 6 df and
with p = 0.424. Also, I2 was 0.00 and the variance in true
effect sizes was T2 = 0.00, with T = 0.00.
Age at MCI and Dementia Diagnosis
Bilinguals were on average 3.2 years (95% CI: −3.4, 9.7;
Fig. 3) older than monolinguals at MCI diagnosis. This mean
difference was not statistically significant (t = 1.53, two-tailed
p = .223). There was evidence that studies did not share a
common effect size but that the true effects varied (Q = 8.91,
df = 3, p = .031). Approximately 66% of the observed variance reflected the difference in true effect sizes rather than
sampling error (I2 = 66.34). The variance in true effect sizes
was T2 = 11.13, with T = 3.34. Bilinguals were on average
3.3 years (95% CI: 1.7, 4.9; Fig. 4) older than monolinguals
at dementia diagnosis. This mean difference was statistically
significant (t = 4.3, two-tailed p < .001). There was evidence
that studies in this analysis likely did not share a common
effect size but that the true effects varied (Q = 48.24, df = 12,
p < .001). The I2 was 75.12 indicating that approximately 75%
of the observed variance reflected the difference in true effect
sizes rather than sampling error. The variance in true effect
sizes was T2 = 4.83, with T = 2.20. The 95% PIs ranged from
−1.9 to 8.5 years. Overall, in this analysis, we observed a high
degree of heterogeneity.
Subgroup Analysis: Type of Diagnosis (Dementia vs. AD)
We conducted a post hoc subgroup analysis to explore the
source for this heterogeneity. We compared studies including
participants with AD to studies including participants with
dementia. Bilinguals in the AD subgroup (k = 8; Fig. 5) were
on average 4.2 years (95% CI: 2.0, 6.4) significantly older

325 (100%); 75+ years (NA), Grade
school (n = 15), High school (n = 14),
Bachelor’s degree (n = 123),
Master’s degree or higher (n = 173), NA

81 (64%)
Baseline
ML: 4.99 (4.17), 3MSE 78.87 (9.90)
BL:7.70 (4.88), 3MSE 79.56 (15.57)
Follow-up
ML: age 81.10
BL: age 79.31
818 (51%) 73.6 (8.9)
Baseline
ML: 73.8 (9.0), 6.9 (1.5), 26.6 (2.3)
BL: 65.7 (6.6), 14.2 (4.3), 28.7 (1.7)
Follow-up
ML: 78.1 (6.1), 6.5 (1.6), 25.3 (2.3)
BL: 76.0 (7.7), 12.0 (2.4), 26.8 (1.6)
ML: 576 (61.6%), 76.1 (6.2), 10.7 (2.8), 3MS 91.2 (5.7)
BL: 54 (70.4%), 75.5 (5.6), 12.4 (4), 91.1 (5.6)
ESL: 360 (60.6%), 75.7 (6.4), 8.7 (3.5), 87.4 (6.9)

Hack et al., 2019

Lawton et al., 2015

Model 1: 1.06 (0.69, 1.63)
Model 2: .13 (0.73, 1.79) Model 3: 7
(0.67, 1.72) Model 4: (0.61, 1.59)
Time 1 3MS, Time 2 3MS, and Change
in the 3MS:
Unadjusted model, English bilingual:
Time 1, 0.6 (−1.8, 2.9), Time 2, 2.5
(−0.7, 5.7), Changed in 3MS, −1.7
(−4.2, 0.8)
Better self-rated bilingualism was associated
with lower odds of dementia conversion.
Each point on the self-report scale was
associated with 0.291 lower log odds
of conversion to dementia

ML 54 (9.4%), 492 (85.4%)
BL 6 (11.1%), 46 (85.2%)
ESL 35 (9.7%), 285 (79.2%)

Self-report (four-point Likert-type)
DSM-III
Probable and possible AD, VaD, LBD,
and other dementias

ML: 198/637
BL: 86/344

BL did not decrease risk of dementia
(p = .50) or AD (p = .36), even after
adjusting for age and sex (p = .29)

ML: 102 (13.86%), 634
(86.14%)
BL: 10 (12.2%), 72 (87.8)

Language History Questionnaire
DSM-IV, NINCDS–ADRDA
AD, VaD, LBD, FLD, PD, and UD

Self-report
ML: Dementia 9.4%. 3MS 91.2 (5.7)
BL: Dementia 11.1, 3MS 91.1 (5.6)
ESL: Dementia 9.7%, 3MS 87.4 (6.9)

BL did not decrease the risk of dementia
p = .72, AD p = .59, or VaD p = .53

Bilingualism was not associated with
a reduced risk of dementia
(OR: 1.17, 95% CI: 0.69, 1.98)

% with dementia ML/BL % RR, OR, HR
no dementia ML/BL

Questionnaire developed by the School
ML: 27/109; BL: 82/109
Sisters
ML: 60/216; BL: 156/216
of Notre Dame
DSM-IV, ADLs, CERAD, MMSE, Delayed
Word Recall, Verbal Fluency, Boston
Naming, Constructional Praxis
ARSMA-II
ML: 54/1154
BL: 27/624

Language measure, dementia
diagnosis,
severity, and type

Effect size

SD: Standard Deviation; CI: Confidence Intervals; ML: Monolinguals; BL: Bilinguals; ESL: English as a Second Language; ADLs: Activities of Daily Living; CERAD: Consortium to Establish a Registry
for Alzheimer’s Disease; AD: Alzheimer’s Disease; VaD: Vascular Dementia; FLD: Frontal Lobe Dementia; PD: Parkinson’s Disease; DLB: Dementia with Lewy bodies; UD: Unspecified dementia;
SNAP: Suspected Non-Alzheimer Pathophysiology; MMSE: Mini-Mental State Examination; 3MS: Modified Mini-Mental State; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders Version
Four; (ADDTC) NINCDS-ADRDA: (Alzheimer Disease Diagnostic and Treatment Centers) National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and
Related Disorders Association; ICD-10: International Statistical Classification of Diseases and Related Health Problems; CDR: Clinical Dementia Rating; DSM-III: Diagnostic and Statistical Manual of
Mental Disorders, Third Edition; RR: Relative Risk; OR: Odds Ratios; HR: Hazard Ratios; NA: Not Available

Zahodne et al., 2014 ML: 637 (72%), 75.66 (5.79), 5.05 (3.61)
BL: 430 (64%), 74.78 (5.66), 8.30 (4.22)

Yeung et al., 2014

Ljungberg et al.,
2016

N (% female); mean age (SD), Education level,
MSSE/3MSE

Study characteristics

Longitudinal prospective studies investigating the relationship between bilingualism and dementia.

Study

Table 4
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than monolinguals (t = 4.13, two-tailed p = .002). Bilinguals
in the dementia subgroup (k = 5; Fig. 5) were on average
1.9 years (95% CI: −0.9, 4.7) older than monolinguals, but
this between-group difference was not statistically significant
(t = 1.52, two-tailed p = .157). We also compared the mean
difference for the AD and dementia subgroups to explore
whether there were any significant differences between the
two subgroups (Fig. 5). The mean difference in years (2.3,
95% CI: −5.9, 1.2) between the two subgroups was not statistically different (F = 2.04, df = 1, 11, two-tailed p = 0.181).
The pooled estimates for heterogeneity in this subgroup analysis were T2 = 4.83, T = 2.20, I2 = 75.12, Q = 48.24, with df =
12, and p < .001.
Subgroup analysis: immigration status (adjusted vs. did not
adjust for immigration)
We conducted a post-hoc subgroup analysis (Fig. 6) exploring
whether immigration status was a potential source of heterogeneity. Bilinguals in studies adjusting for immigration status
(k = 8) were on average 3.1 years (95% CI: 0.9, 5.2) older than
monolinguals at dementia diagnosis (t = 3.17, two-tailed
p = .009). In studies that did not adjust for immigration status
(k = 5), bilinguals were on average 3.6 years (95% CI: 0.8,
6.5) older than monolinguals at dementia diagnosis (t = 2.97;
two-tailed p = .018). The mean difference in years (0.5, 95%
CI: −4.1, 3.0) between the two subgroups was not statistically
different (F = 0.10, df = 1, 11, two-tailed p = 0.752). The
pooled estimates for heterogeneity in this subgroup analysis
were T2 = 4.83, T = 2.20, I2 = 75.12, Q = 48.24, with df = 12,
and p < .001.
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Small-Study Effects
To address small-study effects, we generated funnel plots
(Figs. 9 and 10). One funnel plot (Fig. 9) shows the observed
(white dots) and imputed (black dots) effect sizes. Here, visual
inspection showed that the observed data points tend to cluster
on the right-hand side of the funnel plot indicating a minor
asymmetry, suggesting the presence of small-study effects.
However, Egger’s test was not significant with an intercept
of 1.03 and CIs including −2.15 and 4.20 and with a t value
of 0.71, df = 11, and a 1-tailed p value of 0.246. The Duval and
Tweedie’s Trim and Fill test showed that the adjusted effect
size (black diamond) would be 2.7 (95% CIs 1.3, 4.1) if the
imputed studies had been included in the analysis. This indicates that even the adjusted effect size remained statistically
significant.
Visual inspection of the second funnel plot (Fig. 9) for the
meta-analysis on disease severity (Fig. 10) showed a slight
asymmetry on the right-hand side of the plot indicating a minor asymmetry, suggesting the presence of small-study effects. However, Egger’s test was not significant (one-tailed p
value of 0.420) with an intercept of −0.267 (95% CI: −3.158,
2.623) and a t-value of 0.21 with df = 11. The Duval and
Tweedie’s Trim and Fill showed that the adjusted effect size
(black diamond) would be 0.05 (95% CI: −0.10, 0.21) if the
imputed studies had been included in the analysis. Even in the
likelihood of small-study effects or publication bias (De
Bruin, Treccani, & Della Sala, 2015), the adjusted effect size
remained similar to the observed effect size.

Discussion
Disease Severity
There was no significant difference between mono- and bilinguals in disease severity at the age of dementia diagnosis
(Hedges’ g = 0.05; 95% CI: −0.13, 0.24; t = 0.62, two-tailed
p = .547; Fig. 7). The Q-value was 33.82 with df = 11 and
p < .001. Approximately 67% (I2) of the observed variance
reflected the difference in true effect sizes rather than sampling
error. The variance in true effect sizes was T2 = .05 and T = .21.
The PIs ranged between −0.47 and 0.57 MMSE points.

While some studies have linked bilingualism to a delay in AD
symptom onset and dementia diagnosis (Perani et al., 2017;
Perquin et al., 2013; Schweizer et al., 2012), others have not
reported such benefits (Mukadam et al., 2017). Some authors
have argued that education and immigration status, among
other confounders, may influence the relationship between bilingualism and dementia in cross-sectional studies (Mukadam
et al., 2017). As such, further research is needed (Del Maschio
et al., 2018; Grundy & Anderson, 2017; Woumans, Versijpt,
Sieben, Santens, & Duyck, 2017).

Meta-Analysis of Longitudinal Prospective Studies:
Risk of Dementia

Mild Cognitive Impairment

We performed a meta-analysis on longitudinal prospective
studies (Fig. 8). Results from this meta-analysis (k = 5) showed
that bilingualism was not associated with a reduction in the risk
of dementia (OR: 0.89; 95% CI: 0.68, 1.16, t = −1.22, twotailed p = 0.289) when compared to monolingualism. There
was no evidence of heterogeneity (Q = 3.22, df = 4, p = .522;
I2 = 0.00; T2 = 0.00; T = 0.00).

Meta-analytic results did not suggest that bilingualism delays
the diagnosis of MCI. Due to the small number of included
studies (k = 4) and small sample sizes (monolinguals n = 131;
bilinguals n = 169), it is likely that this meta-analysis was
underpowered and consequently, a type II error is possible
(Hedges & Pigott, 2001). Studies had recruited participants
with different types of MCI including single-domain amnestic
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★
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Estanga 2016
Lawton 2015
Ossher 2013
Perani 2017
Ramakrishnan
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Schweizer 2012
Woumans 2015
Yeung 2014
Zheng 2018
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–
★
★
★
–
★

–
–
–
–
–
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–
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Alladi 2017
Alladi 2013
Bialystok 2014
Bialystok 2007
Chertkow 2010
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Clare et al., 2016
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Controls for most Controls for any Assessment
important factor additional factor of outcome
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and multiple-domain amnestic MCI (Ossher et al., 2012),
amnestic and non-amnestic MCI (Ramakrishnan et al.,
2017), or did not specify the subtype (Bialystok et al.,
2014). Given the low number of included studies in this meta-analysis, we could not conduct a subgroup analysis to explore whether bilingualism was associated with a delayed diagnosis of MCI in relationship to the different subtypes of
MCI. Of note, while MCI is a risk factor for dementia and
AD, not all individuals with MCI will progress to AD or
dementia (Albert et al., 2011). Therefore, the putative beneficial effects of bilingualism may be more salient at the beginning of the AD clinical spectrum rather than in milder forms of
cognitive impairment such as MCI. Notably, a longitudinal
study showed that foreign language instruction during childhood and adolescence lowered the risk of non-amnestic MCI
but not amnestic MCI (Wilson et al., 2015), which supports
some of the primary cross-sectional studies (Bialystok et al.,
2014; Ossher et al., 2012; Ramakrishnan et al., 2017).

Age of AD Symptom Onset

Selection of the
non-exposed
cohort

Comparability
Selection
Study

Table 6

Risk of bias for longitudinal prospective studies.

Outcome

Was followup
long enough
for outcomes
to occur

Adequacy of
follow up of
cohorts

6
6

Total/
9
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Our meta-analysis showed that bilinguals experienced AD symptoms on average 4.7 years later than monolinguals. While we did
not observe significant heterogeneity, given the low number of
studies (k = 7), caution in interpreting these findings as homogenous is warranted (Ioannidis, Patsopoulos, & Evangelou, 2007).
These findings are in line with previous studies which show that
speaking multiple languages is associated with better cognitive
health in old age (Ihle, Oris, Fagot, & Kliegel, 2016; Kavé, Eyal,
Shorek, & Cohen-Mansfield, 2008). Notably, the included studies did not provide a comprehensive profile of participants’ spoken languages, and because of this, we could not further investigate whether second-language proficiency, frequency of use,
and age of acquisition played a moderating role in the observed
delay in AD symptom onset (Del Maschio et al., 2018). When
assessing AD symptom onset, researchers asked participants to
retrospectively recall the age at which participants first began
noticing AD symptoms. However, participants’ recall is often
inaccurate and recall bias might have distorted participants’ reported estimates questioning its accuracy (Van den Bergh &
Walentynowicz, 2016). In this meta-analysis (Fig. 2) studies
tended to have small sample sizes (N median: 68.5) questioning
the precision of the observed effect sizes (Cumming, 2014).
Consequently, whether the estimate is close to the true value in
this meta-analysis remains uncertain.

Age of Dementia and AD Diagnosis
Bilinguals were diagnosed with dementia on average 3.3 years
later than monolinguals. According to the 95% PI (−1.9 to
8.5), we could expect that in some 95% of all populations
comparable to those in this meta-analysis (Fig. 4), the
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association between bilingualism and dementia may be
strong, while in others, this association may be absent or
may even tend to be in the opposite direction (Riley et al.,
2011). Therefore, the beneficial association between bilingualism and delayed dementia diagnosis may appear only in
some populations. While there are several possible explanations for wide PIs such as high risk of bias, we explored
whether clinical differences across studies may be associated
with the magnitude of the observed effect size in the metaanalysis in Fig. 4 (Sterne et al., 2011; Thompson, 1994). To
address this, we conducted a post hoc subgroup analysis
(Borenstein & Higgins, 2013; Oxman & Guyatt, 1992) comparing studies including participants with dementia (irrespective of etiology) to studies including participants with AD
(specific etiology). In this analysis, bilinguals were not older
than monolinguals at dementia diagnosis (mean difference:
1.9 years) but were 4.2 years older at AD diagnosis. Here,
the between-subgroup mean difference did not differ. Low
statistical power, as indicated by wide CI, the low number of
studies per subgroup (dementia: k = 5; AD: k = 8), and a low
sample sizes per study might explain the lack of difference in
the dementia subgroup and in the between-subgroup analysis
(Riley et al., 2011).
However, subgroup analyses are by default observational
and because of this, we cannot be certain that participants in
each subgroup were similar other than in the type of diagnosis.
For example, the AD subgroup might have included a large
portion of participants who could speak several languages and
the dementia subgroup might have included bilinguals who
spoke only two languages. Therefore, while bilinguals vs.
monolinguals were older at AD but not at dementia diagnosis,
we cannot be certain that this was due to differences in the
type of diagnosis, and that findings should only be interpreted
as hypothesis-generating (Thompson & Higgins, 2002).

Risk of Dementia
The meta-analysis including prospective studies showed no
significant risk reduction in developing dementia among bilinguals compared to monolinguals. Our effect size favored bilinguals more than the effect size from the previous meta-analysis
Fig. 2 Forest plot showing the
mean difference (MD) in the age
of Alzheimer's Disease symptom
onset between bilinguals (BL)
and monolinguals (ML); lower
limit (LL), upper limit (UL); CI:
confidence intervals

[odds ratio: 0.89; 95% CI: 0.68–1.16; (Mukadam et al., 2017)].
From our systematic review, we decided to exclude one study
because it did not clearly define its control group as monolingual (Sanders et al., 2012), but it was included in the previous
meta-analysis (Mukadam et al., 2017). The difference in the
included studies between our and the previous meta-analysis
might explain the difference in the magnitude of the effect sizes.
Moreover, while results showed no risk reduction in dementia
among bilinguals, the trend favoring bilinguals in our metaanalysis (Fig. 7) needs to be carefully considered. Given the
low number of studies (k = 5), our meta-analysis might not have
reached sufficient statistical power to detect a true effect
(Hedges & Pigott, 2001). The CIs in each study were relatively
wide indicating low statistical power and poor precision
(Cumming, 2014). Therefore, each study was also likely underpowered to detect a true effect, if such an effect existed (Ioannidis,
2005, 2008). We did not find evidence of heterogeneity in this
meta-analysis. Given the low number of studies in this meta-analysis, the Q statistic was likely underpowered, however. Notably,
lack of heterogeneity does not necessarily indicate homogeneity
(Ioannidis et al., 2007); interpreting a non-significant heterogeneity
test in a meta-analysis with few studies is problematic (Rücker,
Schwarzer, Carpenter, & Schumacher, 2008).

Possible Mechanisms and Disease Severity
at Dementia Diagnosis
Some authors have argued that while cross-sectional studies generally tend to show a later dementia diagnosis for bilinguals vs.
monolinguals, these studies are more susceptible to the confounding effects of education or cultural differences (Mukadam
et al., 2017). Given that our meta-analyses included studies that
had adjusted for education, it is unlikely that education had confounded the observed delays in dementia and AD diagnoses
among bilinguals. We also conducted a subgroup meta-analysis
comparing studies that had adjusted for immigration to those that
did not explicitly mention participants’ immigration status. This
analysis found that bilinguals were older than monolinguals at
dementia diagnosis regardless of subgroup membership. This
suggests that immigration might not have played a role in
delaying the age of dementia diagnosis in bilinguals relative to

Study name

Alladi 2013
Bialystok 2007
Bialystok 2014
Clare 2014
Craik 2010
Woumans 2015
Zheng 2018
Total

Statistics for each study

BL
mean age

ML
mean age

68.6
75.5
78.2
76.9
77.7
76.1
70.9

65.4
71.4
70.9
73.7
72.6
71.5
63.7

MD

LL

UL p-Value

3.2
4.1
7.3
3.2
5.1
4.6
7.3
4.7

0.7
1.5
2.7
-0.5
2.7
1.0
4.0
3.3

5.7
6.7
11.9
6.9
7.5
8.2
10.5
6.1

MD and 95% CI

0.013
0.002
0.002
0.086
0.000
0.013
0.000
0.000
-12.0

Q = 6, df = 6, p = .424; I2 = 0.00; T = 0.00; T2 = 0.00

-6.0

Favours monolinguals

0.0

6.0
Favours bilinguals

12.0
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Fig. 3 Forest plot showing the
mean difference (MD) in the age
of mild cognitive impairment diagnosis between bilinguals (BL)
and monolinguals (ML); LL:
lower limit, UP: upper limit; CI:
confidence intervals
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Statistics for each study

Study name

BL
mean age
70.0
79.4
72.6
65.2

Bialystok 2014
Ossher 2013a
Ossher 2013b
Ramakrishnan 2017
Total

ML
mean age
66.5
74.9
75.2
58.1

MD

LL

UL

p-Value

3.5
4.5
-2.6
7.1
3.2

-2.7
0.9
-7.3
2.4
-3.4

9.7
8.1
2.1
11.8
9.7

0.266
0.014
0.280
0.003
0.223

MD and 95% CI

-12.0

0.0

-6.0
Favours bilinguals

Q = 8.91, df = 3, p = 0.031;

I2 =

66.34; T = 3.34;

T2 =

of cognition despite the presence of a neurodegenerative disease such as AD (Perquin et al., 2013; Stern, 2012).
Supporting findings from our meta-analysis on disease severity, behavioral data indicated that mono- and bilinguals did
not significantly differ in executive functions at AD diagnosis
despite bilinguals being significantly older (Bialystok et al.,
2014). Computed tomography scans also revealed greater atrophy of the medial temporal lobe at AD diagnosis in bilinguals vs. monolinguals matched for disease severity and despite monolinguals having higher education and job status
(Schweizer et al., 2012). The medial temporal lobe is a region
particularly affected by AD (Clerx et al., 2013; Visser et al.,
2002). Moreover, bilinguals showed greater cerebral
hypometabolism than monolinguals, which is indicative of
greater neurodegeneration, and outperformed monolinguals
in short- and long-term verbal and visuospatial memory, but
not in language tasks (Perani et al., 2017). Given the disagreement in the field regarding the exact underlying mechanisms
of bilingualism thought to promote cognitive reserve (GarcíaPentón et al., 2016a, 2016b), we are currently conducting a
systematic review investigating the underlying brain mechanisms of bilingualism in non-clinical and clinical individuals
with MCI or dementia (Brini et al., 2018a).
Because studies did not generally measure participants’
socioeconomic status, it was not possible to examine whether
this factor might have contributed to the observed delays in

Study name

Alladi 2013
Alladi 2017
Bialystok 2007
Bialystok 2014
Chertkow 2010
Clare 2014
Craik 2010
Lawton 2015
Ljungberg 2016
Perani 2017
Schweizer 2012
Woumans 2015
Zheng 2018
Total

12.0

11.13

monolinguals in these studies. It is noteworthy to highlight that
while some studies had mentioned participants’ migration status,
it was occasionally problematic to discern whether authors had in
fact adjusted for migration status because there was no statement
explicitly addressing the analytical approach for adjusting for this
variable.
Even if bilinguals were delaying seeking medical attention
due to cultural differences, we would still expect them to demonstrate greater cognitive impairment than monolinguals at
dementia diagnosis. However, we found no difference
(Hedges’ g = 0.05, 95% CI: −0.13, 0.24) between mono- and
bilinguals on disease severity at dementia diagnosis. This suggests that in some settings, bilingualism may be more beneficial than monolingualism to help maintain cognitive function
for a longer period of time despite the presence of ongoing
neuropathology (Gold, 2015). It is possible that bilingualism
may help in maintaining cognitive health for a longer period
of time, protecting against the impending effects of AD on
cognition (Bak et al., 2014; Gold, 2015). There is evidence
to suggest that bilingualism is associated with higher cognitive
function in old age (Ihle et al., 2016; Kavé et al., 2008) even
after adjusting for differences in intelligence levels during
childhood (Bak et al., 2014). Some authors have advanced
the proposition that bilingualism may enhance cognitive reserve, which refers to the ability to maintain functioning levels

Fig. 4 Forest plot showing the
mean difference (MD) in the age
of dementia diagnosis between
bilinguals (BL) and monolinguals
(ML); LL: lower limit, UP: upper
limit; CI: confidence intervals

6.0
Favours monolinguals

Statistics for each study

BL
mean age
68.1
64.2
78.6
78.2
77.6
79.3
80.8
81.1
80.7
77.1
78.9
77.3
74.4

ML
mean age
63.4
61.0
75.4
70.9
76.7
76.2
76.5
79.3
81.9
71.4
77.3
72.5
67.5

MD
4.7
3.2
3.2
7.3
0.9
3.0
4.3
-1.8
-1.2
5.7
1.6
4.8
6.9
3.3

LL
3.0
0.4
0.6
2.8
-0.3
-0.4
1.9
-4.9
-5.0
3.7
-3.0
1.4
3.6
1.7

MD and 95% CI

UL p-Value
6.4 0.000
6.0 0.023
5.8 0.014
11.8 0.001
2.1 0.143
6.4 0.080
6.7 0.000
1.3 0.257
2.6 0.537
7.7 0.000
6.2 0.492
8.2 0.005
10.2 0.000
4.9 0.000
-12.0

Q = 48.24, df = 12, p < .001; I2 = 75.12; T = 2.20; T2 = 4.83
95% PI: -1.9 to 8.5 years

-6.0
Favours monolinguals

0.0

6.0
Favours bilinguals

12.0
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Group by
Diagnosis

AD
AD
AD
AD
AD
AD
AD
AD
AD: total
Dementia
Dementia
Dementia
Dementia
Dementia
Dementia: total

Study name

Statistics for each study
BL
mean age

ML
mean age

Bialystok 2014
Chertkow 2010
Clare 2014
Craik 2010
Perani 2017
Schweizer 2012
Woumans 2015
Zheng 2018

78.2
77.6
79.3
80.8
77.1
78.9
77.3
74.4

70.9
76.7
76.2
76.5
71.4
77.3
72.5
67.5

Alladi 2013
Alladi 2017
Bialystok 2007
Lawton 2015
Ljungberg 2016

68.1
64.2
78.6
81.1
80.7

63.4
61.0
75.4
79.3
81.9

MD and 95% CI

MD

LL

UL

p-Value

7.3
0.9
3.0
4.3
5.7
1.6
4.8
6.9
4.2
4.7
3.2
3.2
-1.8
-1.2
1.9

2.8
-0.3
-0.4
1.9
3.7
-3.0
1.4
3.6
2.0
3.0
0.4
0.6
-4.9
-5.0
-0.9

11.8
2.1
6.4
6.7
7.7
6.2
8.2
10.2
6.4
6.4
6.0
5.8
1.3
2.6
4.7

0.001
0.143
0.080
0.000
0.000
0.492
0.005
0.000
0.002
0.000
0.023
0.014
0.257
0.537
0.157
-12.0

-6.0

0.0

Favours bilinguals

Q = 48.24, df = 12, p < .001; I2 = 75.12; T = 2.20; T2 = 4.83

6.0

12.0

Favours monolinguals

Fig. 5 Forest plot showing the mean difference (MD) in the subgroup
meta-analysis comparing studies including participants with AD to studies including participants with dementia on the age of AD and dementia

diagnosis between bilinguals (BL) and monolinguals (ML); AD:
Alzheimer’s disease; LL: lower limit, UP: upper limit; CI: confidence
intervals

dementia diagnosis among bilinguals. The incidence of dementia is higher in certain ethnic minorities than
in Caucasian individuals (Mehta & Yeo, 2017), suggesting
that socioeconomic and cultural factors may play a role in
the observed relationship between bilingualism and dementia.
Researchers have extensively debated how to quantify bilingualism (Del Maschio et al., 2018; Luk & Bialystok, 2013).
While studies have tended to categorize participants between
mono- and bilinguals (Del Maschio et al., 2018), bilingualism
is a multidimensional variable that extends on a continuum
(Luk & Bialystok, 2013). For example, factors including the
number of languages one can speak, age of acquisition, proficiency, and frequency of use in the second language likely
interact with one another and may explain differences in the
observed delay in dementia among bilinguals (Del Maschio

et al., 2018). However, the studies included in our metaanalysis did not formally assess these factors (Table 5–6),
and because of this, we could not examine whether the different dimensions of bilingualism (Del Maschio et al., 2018; Luk
& Bialystok, 2013) contributed to the observed heterogeneity
in some of our meta-analyses.

Group by
Immigraton status

Study name

No
No
No
No
No
No: total
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes: total

Lawton 2015
Perani 2017
Schweizer 2012
Woumans 2015
Zheng 2018

BL
mean age
81.1
77.1
78.9
77.3
74.4

ML
mean age
79.3
71.4
77.3
72.5
67.5

Alladi 2013
Alladi 2017
Bialystok 2007
Bialystok 2014
Chertkow 2010
Clare 2014
Craik 2010
Ljungberg 2016

68.1
64.2
78.6
78.2
77.6
79.3
80.8
80.7

63.4
61.0
75.4
70.9
76.7
76.2
76.5
81.9

Sources of Uncertainty and Risk of Bias
in Cross-Sectional and Longitudinal Prospective
Studies
From our risk of bias assessment within studies, it is clear that
one major source of uncertainty concerned how representative
the samples were and whether the exposure had been measured appropriately (Table 5). In cross-sectional studies,

Statistics for each study

MD
-1.8
5.7
1.6
4.8
6.9
3.6
4.7
3.2
3.2
7.3
0.9
3.0
4.3
-1.2
3.1

LL
-4.9
3.7
-3.0
1.4
3.6
0.8
3.0
0.4
0.6
2.8
-0.3
-0.4
1.9
-5.0
0.9

UL
1.3
7.7
6.2
8.2
10.2
6.5
6.4
6.0
5.8
11.8
2.1
6.4
6.7
2.6
5.2

MD and 95% CI

p-Value
0.257
0.000
0.492
0.005
0.000
0.018
0.000
0.023
0.014
0.001
0.143
0.080
0.000
0.537
0.009
-12.0

Q = 48.24, df = 12, p < .001; I2 = 75.12; T = 2.20; T2 = 4.83

Fig. 6 Forest plot showing the mean difference (MD) in the subgroup
meta-analysis comparing studies that had adjusted for immigrations status
to studies that had not adjusted for immigration status on the age of
dementia diagnosis between bilinguals (BL) and monolinguals (ML);

-6.0
Favours monolinguals

0.0

6.0

12.0

Favours bilinguals

LL: lower limit, UP: upper limit; CI: confidence intervals. Studies that
had not adjusted for immigration status are categorized as No and studies
that had adjusted for immigration status are categorized as Yes.
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Fig. 7 Forest plot showing the
standardized mean difference
(Hedges’s g) in the degree of
disease severity at dementia
diagnosis between bilinguals
(BL) and monolinguals (ML);
LL: lower limit, UP: upper limit;
CI: confidence intervals
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Study name

Statistics for each study

Hedges’s
g
Alladi 2013
0.28
Alladi 2017
0.21
Bialystok 2007 -0.18
Bialystok 2014 -0.26
Chertkow 2010 -0.05
Clare 2014
-0.38
Craik 2010
-0.19
Lawton 2015
0.06
Ljungberg 2016 0.66
Perani 2017
0.29
Woumans 2015 -0.12
Zheng 2018
0.50
0.05
Total

LL

UL p-Value

0.12
-0.08
-0.47
-0.71
-0.21
-0.83
-0.46
-0.40
0.01
-0.14
-0.46
0.15
-0.13

0.44
0.51
0.11
0.19
0.11
0.06
0.08
0.51
1.31
0.71
0.21
0.85
0.24

Hedges's g and 95% CI

0.000
0.150
0.230
0.259
0.545
0.094
0.159
0.808
0.046
0.187
0.477
0.005
0.547
-1.50

Q = 33.82, df = 11, p < .001; I2 = 67.47; T = .21; T2 = .05
95% PI: -0.47, 0.57

because no study formally assessed monolingualism, the extent to which participants were truly monolinguals remains
unclear. This would have been an important factor to assess
because exposure to foreign languages through schooling or
the media is ubiquitous nowadays (Laine & Lehtonen, 2018),
questioning whether the monolinguals in our included studies
were in fact, truly monolinguals. Generally, bilingualism was
poorly defined, measured, or did not carry a specific definition. While researchers commonly defined bilingualism as
“speaking two or more languages,” they did not routinely
measure additional languages. This would have been a relevant factor to measure because some studies point to a doseresponse relationship (Antoniou & Wright, 2017) with increasing number of languages generating a greater delay in
the onset of dementia (Alladi et al., 2013; Chertkow et al.,
2010; Clare et al., 2016), protection against cognitive impairment (Perquin et al., 2013), and greater cognitive health in
older individuals (Ihle et al., 2016).
Fig. 8 Forest plot showing the
odds of developing dementia
between monolinguals and
bilinguals; OR: odds ratio; LL:
lower limit, UP: upper limit; CI:
confidence intervals

Study name

Hack 2019
Lawton 2015
Ljungberg 2016
Yeung 2014
Zahodne 2014

0.00

-0.75
Favours bilinguals

0.75

1.50

Favours monolinguals

The assessment of participants’ language profiles and by
extension, their representativeness, was also questionable in
longitudinal prospective studies (Table 6). In one study, bilingualism was not associated with reduced dementia risk but
those reporting speaking a second language very well had a
14% lower risk of developing dementia than those who reported not at all well (Zahodne et al., 2014). This questions
whether participants who reported speaking a second language “not at all well” should have been classed as bilinguals
or monolinguals and supports the notion that participants’
language profiles should be treated as a continuous rather than
a dichotomous variable (Luk & Bialystok, 2013). While other
studies did not show a risk reduction in dementia among bilinguals, it is likely that they were underpowered. For example, one study included 736 monolinguals but only 82 bilinguals with 102 developing dementia in the monolingual group
and 10 among bilinguals (Ljungberg et al., 2016).
Furthermore, only three studies adopted a questionnaire to

Statistics for each study

OR

LL

1.17
0.92
0.86
1.06
0.74
0.89

0.69
0.57
0.43
0.69
0.55
0.68

OR and 95% CI

UL p-Value
1.98
1.47
1.73
1.63
0.99
1.16

0.563
0.723
0.678
0.781
0.045
0.289
0.1 0.2

0.5

1

2

5

10

Favours bilinguals Favours monolinguals
Q = 3.22, df = 4, p = .522; I2 = 0.00; T = 0.00; T2 = 0.00
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Fig. 9 Funnel plot showing standard error by difference in means with observed (white dots) and imputed estimates (black dots) for the meta-analysis
including dementia as the outcome

measure bilingualism (Hack et al., 2019; Ljungberg et al.,
2016; Zahodne et al., 2014). Thus, differences in the
operationalization and measurement of bilingualism, as well
as relatively small sample sizes, question the internal validity of the
longitudinal prospective studies (IntHout, Ioannidis, Borm, &
Goeman, 2015).
Further, while some cross-sectional studies adjusted for important confounders such as education and occupation status,
several studies did not specify whether they had adjusted for
other likely confounders nor did they routinely report

participants’ immigration status (Fuller-Thomson, 2015; FullerThomson & Kuh, 2014) or levels of physical activity. Levels of
physical activity may be an important factor to assess as bilingualism may benefit sedentary individuals (Brini et al., 2018b)
differently than highly physically active individuals (Sterne et al.,
2011). Since the majority of studies did not provide evidence of
power calculations, it was unclear whether they had sufficient
statistical power to detect an effect if one existed particularly
when adjusting for genes (Ioannidis, 2008; Sham & Purcell,
2014). For example, bilingualism may benefit participants with

0.0

Standard Error

0.1

0.2

0.3

0.4

-2.0

-1.5

-1.0

-0.5

0.0

0.5

1.0

1.5

2.0

Fig. 10 Funnel plot showing standard error by difference in standardized means (Hedges’s g) with observed estimates for the meta-analysis including
disease severity at dementia diagnosis as the outcome
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the apolipoprotein E (APOE) ε4 allele, the main genetic risk
factor for AD (Galimberti & Scarpini, 2016; Liu, Kanekiyo,
Xu, & Bu, 2013), differently than those without the APOE ε4.
Similar to the cross-sectional studies, longitudinal prospective
studies did not consider participants’ baseline risk of dementia.
Although one study adjusted for the APOE ε4 (Ljungberg et al.,
2016), which is a risk factor for AD (Brini et al., 2018b), no other
prospective study considered other genetic risk factors implicated in
AD (Naj, Schellenberg, & Consortium, 2017). Only 147 participants (across mono- and bilinguals) were APOE ε4 carriers
(Ljungberg et al., 2016). Of note, whether APOE ε4 increases the
risk of vascular dementia (Rohn, 2014), frontotemporal dementia
(Verpillat et al., 2002), dementia with Lewy bodies (Lovati et al.,
2010), and Parkinson’s disease (Fagan & Pihlstrøm, 2017) is unclear (Lovati et al., 2010). Therefore, adjustment for the APOE ε4
likely did not reach sufficient statistical power (Sham & Purcell,
2014) in this study (Ljungberg et al., 2016) and its clinical relevance
to other dementia etiologies may have been limited (Lovati et al.,
2010). The authors also did not analyze other variants of the APOE
including the ε2, which may confer protection against AD (Liu
et al., 2013).

Small-Study Effects
While our funnel plots showed slight asymmetry indicating
possible small-study effects (Sterne, Egger, & Smith, 2001),
Egger’s tests were not significant. However, results from
Egger’s test should be interpreted with caution, because in
the absence of severe bias, this test has low statistical power
(Sterne, Gavaghan, & Egger, 2000). One possible source of
small-study effects is publication bias (Egger, Smith,
Schneider, & Minder, 1997), which is prevalent in the social
(Franco, Malhotra, & Simonovits, 2014) and cognitive sciences (Ioannidis, Munafo, Fusar-Poli, Nosek, & David,
2014). More notably for this systematic review, it is likely
present in the field of bilingualism research, too (De Bruin
et al., 2015); although others (Bialystok, Kroll, Green,
MacWhinney, & Craik, 2015) have contested these findings
(De Bruin et al., 2015). Therefore, despite the non-significant
Egger’s tests, there are reasons to believe that publication bias
may be present in this field of research. In light of this, the
Duval and Tweedie’s Trim and Fill test (Duval & Tweedie,
2000) showed that after imputing the estimated missing studies, bilinguals would be on average 2.7 years (95% CI: 1.3,
4.1) older than monolinguals at the time of dementia diagnosis. Even in the likelihood of publication bias (De Bruin et al.,
2015), the observed effect size in this meta-analysis (Fig. 4)
would not change by a large margin.
Several of our included studies had small sample sizes,
which can increase the risk of type I error (Ioannidis, 2005)
and inflate the effect size (Ioannidis, 2008), which can result in
funnel plot asymmetry (Sterne et al., 2011). For example, if
the association between bilingualism and dementia is driven
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by a dose-response relationship (Alladi et al., 2013; Chertkow
et al., 2010; Clare et al., 2016; Ihle et al., 2016), smaller studies with a higher portion of multilingual participants may generate greater effect sizes resulting in funnel plot asymmetry
(Egger et al., 1997). Moreover, as mentioned previously, bilingualism may benefit participants who occupy a higher
baseline risk of dementia (e.g., by virtue of genetic risk) differently, which could also explain funnel plot asymmetry
(Sterne et al., 2011). However, because most studies did not
report data on the number of spoken languages or participants’
baseline dementia risk, we could not explore whether multilingualism may have contributed to funnel plot asymmetry.

Limitations
A limitation of our meta-analyses was the inclusion of all crosssectional studies regardless of language status. Most studies did not
precisely report how many languages were spoken by their bilingual
cohorts. Therefore, from our meta-analyses, it remains unclear
whether the number of languages a person can speak plays a role
in delaying the onset of dementia. As noted above, however, some
evidence suggests that the number of languages could play a role in
the risk and delay of dementia (Chertkow et al., 2010; Clare et al.,
2016). Additionally, in a subgroup meta-analysis, we compared
studies that recruited participants with dementia and AD. In the
dementia subgroup, however, participants were diagnosed with different forms of dementia. This is a limitation because, from this
subgroup, it was not possible to discern whether bilingualism was
distinctively related to different dementia etiologies. Furthermore,
this subgroup analysis was likely underpowered given the small
number of studies (k = 5) and the associated large CIs.
While the results of our meta-analyses on the age of dementia and AD diagnosis are interesting, it is crucial to stress
that the observed relationship between bilingualism and dementia is not causal. Cross-sectional studies are useful when
examining the relationship between two variables and help to
generate hypotheses that may be further tested for causal effects in experimental studies. Particularly for this review, our
risk of bias assessment uncovered several sources of uncertainty due to bias within studies. For example, several factors
such as the poor measurement of bilingualism, the inclusion of
varying types of dementia etiologies, and lack of control over
confounding factors in several of the included studies, leave
us questioning the beneficial link between bilingualism and
dementia.
Most studies did not report how bilinguals had acquired the
second or third language, or participants’ immigration status.
This is a limitation in our meta-analyses because some participants might have acquired the second language through
schooling whereas others might have acquired it due to migrating to a new country. In the former case, participants might
have been diagnosed in their native language (e.g., English)
whereas in the latter case, participants might have been
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diagnosed in their non-native language (e.g., a language other
than the recipient country’s national language). As such, cultural differences (Chandra et al., 2001; Chin et al., 2011) or
language barriers (Lindesay, 1998; Nielsen et al., 2011) might
have contributed to the observed delays in dementia diagnosis
and possibly confounded the relationship between bilingualism and age of dementia diagnosis. Since there was insufficient information regarding what language was used to provide a diagnosis of MCI or dementia among bilinguals, we
could not further explore whether the language of the assessment played a role in the observed delays in any of our
outcomes.

Strengths
Unlike a previous systematic review (Mukadam et al., 2017), results from cross-sectional studies were meta-analyzed to determine
whether bilingualism is associated with a delayed onset of dementia and AD. This allowed us to generate a more precise estimate of
the effect size. In response to previous criticisms (Fuller-Thomson,
2015; Fuller-Thomson & Kuh, 2014; Mukadam et al., 2017), we
explored whether immigration status might have been related to
differences in the age of dementia diagnosis by conducting a subgroup meta-analysis. We have included more recently published
studies that had not been included in the previous systematic review (Mukadam et al., 2017) and therefore, provide a more up to
date review of the available literature. We also registered a study
protocol a priori for this systematic review.

Suggestions for Future Research
Given the lack of a standard definition and measurement tool for
mono- and bilingualism across our included studies, it is critical for
future research to improve the measurement of participants’ language profile. This could mean quantifying the spectrum of language knowledge on a continuum and by measuring proficiency,
frequency of use, and the age of second language acquisition
(Anderson, Mak, Chahi, & Bialystok, 2018; Li, Zhang, Yu, &
Zhao, 2019; Luk & Bialystok, 2013). Researchers could then apply
multiple linear regression (Plonsky & Oswald, 2017) or Bayesian
inference (Ross & Mackey, 2015) to explore whether language
skills can predict the age of dementia symptom onset and diagnosis.
Researchers can apply objective measures for bilingualism (Clare
et al., 2016; Estanga et al., 2017), rather than asking participants or
family members to self-report language status (Alladi et al., 2013;
Chertkow et al., 2010). Formal assessments of second language
proficiency while treating the degree of bilingualism as a continuous
variable (DeLuca, Rothman, Bialystok, & Pliatsikas, 2019; Laine &
Lehtonen, 2018; Luk & Bialystok, 2013) should be applied.
Authors have recently developed questionnaires to quantify participants’ language profiles on a continuum (Anderson et al., 2018)
and to measure language proficiency, dominance, as well as immersion (Li et al., 2019). Researchers might want to establish a priori
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whether they wish to measure bilingualism, the ability to speak two
languages (Anderson et al., 2018) or multilingualism, the ability to
speak three or more languages (Li et al., 2019). Clearly reporting
participants’ immigration status will also be beneficial.
Increasing statistical power will enable partitioning of participants into different dementia etiologies (Nelson et al., 2019) and to
conduct sub-group analyses. While categorizing participants into
dementia subtypes poses several challenges (De Reuck et al.,
2016), applying biomarkers could help researchers in classifying
dementia subtypes (Jack et al., 2016; Perneczky et al., 2016).
Future studies should consider adjusting for variables such as
physical activity, which is associated with the risk of dementia
(Brini et al., 2018b). Researchers wishing to adjust for genetic risk
would need to recruit a large number of mono- and bilinguals to
reach sufficient statistical power for this type of analysis (Sham &
Purcell, 2014) and exclude participants for which the APOE ε4
may not be clinically relevant (Lovati et al., 2010). Additionally,
while bilinguals vs. monolinguals were older at dementia diagnosis, the observed delay does not imply disease-modifying effects
(Galimberti & Scarpini, 2016). Combining behavioral measures
with surrogate biomarkers such as brain data will provide more
robust evidence as to whether bilingualism can help maintain cognitive function despite presence of neuropathology due to dementia (Bialystok, Anderson, & Grundy, 2018; Brini et al., 2018a) and
could reveal potentially disease-modifying properties (Galimberti
& Scarpini, 2016). Researchers wishing to conduct conditional
power calculations for future studies based on our meta-analyses
need to take into consideration heterogeneity when estimating
sample size (Roloff, Higgins, & Sutton, 2013). Finally, to enhance
reporting for observational studies, authors should follow and
clearly state that their study adhered to the Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE)
Statement (Von Elm et al., 2014).

Implications and Conclusion
Identifying factors that can delay the onset of dementia and
AD is a major public health priority (Winblad et al., 2016;
Wortmann, 2012). This is because, a delay in the onset of
AD of five years could reduce AD prevalence by 57% with
concomitant savings of US$627 to US$344 billion in
Medicare costs worldwide (Sperling et al., 2011). At the individual level, delaying the symptom onset of dementia and AD
can also have important benefits for patients, families, and, by
implication, the overall incidence of AD (Cummings,
Morstorf, & Zhong, 2014). Our findings suggest that
speaking two or more languages may be related to an ability
to maintain functional cognition for a longer time compared to
monolingualism. The observed effect sizes may be superior,
under certain settings, to available pharmacological therapies
that delay cognitive decline by 6–12 months and only target
symptoms without modifying the pathogenic or clinical
course of AD (Yiannopoulou & Papageorgiou, 2013).
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While bilingualism appears to be associated with delayed
AD symptom onset, dementia and AD diagnosis, the substantial heterogeneity and several sources of bias challenge the
interpretation of our findings. Until future studies improve
the measurement of participants’ language profiles, increase
sample sizes, comprehensively report sample characteristics
including participants’ ethnicity and birthplace, adjust for
baseline dementia and AD risk (separately), it will be problematic to discern under which settings and to what extent
bilingualism may be beneficial. Precisely because of these
unanswered questions, it is premature to take a stance on the
relevance of bilingualism as a way to delay dementia. We also
disagree that longitudinal prospective studies were “large high
quality prospective studies” (Mukadam et al., 2017). We argue
that longitudinal prospective studies were likely underpowered and carried serious methodological limitations and that,
it is incorrect to conclude evidence of no effect (Mukadam
et al., 2017) from no evidence of an effect (Schünemann
et al., 2019). Given that the observed effect sizes may be
s u p e r i o r t o a v ai l a bl e ph a r m a c ol og i c a l t h er ap i e s
(Yiannopoulou & Papageorgiou, 2013), we agree with others
that researchers should improve study methodology and continue investigating the link between bilingualism and dementia (Del Maschio et al., 2018).
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